Anday, Abid I.
HRN: 11 89 91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2022
MEBENDAZOLE 50MG/ML, 60ML SUSPENSION (BOT)
07/17/2022
07/17/2022
PO
500mg
Now
Stool Exam
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes